Rybelsus

Rybelsus (semaglutide) is a prescription-only oral medication that is approved by the MHRA for weight management in adults. It works by regulating blood sugar levels and reducing appetite, helping patients achieve sustainable weight loss. Rybelsus is specifically designed for adults with a BMI of 27 or higher who have at least one weight-related health condition, or for those with a BMI of 30 or higher. It mimics the natural GLP-1 hormone in the body, which regulates appetite and glucose metabolism, resulting in reduced hunger and better metabolic function. Clinical studies have shown that patients taking Rybelsus can lose an average of 5-10% of their body weight. The treatment has been proven effective in multiple trials, with the STEP program demonstrating significant improvements in weight loss compared to placebo. Rybelsus comes in 3mg, 7mg, and 14mg doses, allowing for personalized treatment. Patients typically start with the 3mg dose, which can be gradually increased to higher strengths based on individual tolerance and weight loss response. At UKWeightloss, we provide comprehensive support throughout your treatment journey. Our UK-registered clinicians conduct thorough consultations, monitor progress, and adjust treatment plans as needed to ensure the best possible outcomes.